Skip to main content
Erschienen in: Calcified Tissue International 2/2014

01.02.2014 | Original Research

Camurati–Engelmann Disease (Progressive Diaphyseal Dysplasia): Reports of an Indian Kindred

verfasst von: Sanjay Kumar Bhadada, Subbiah Sridhar, Ellen Steenackers, Vandana Dhiman, Geert Mortier, Anil Bhansali, Wim Van Hul

Erschienen in: Calcified Tissue International | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Camurati–Engelmann disease (CED, OMIM 131300), or progressive diaphyseal dysplasia, is a rare autosomal dominant skeletal dysplasia, caused by mutations in the transforming growth factor-β1 (TGFβ1) gene. We describe the first Indian CED family with genetic confirmation and presenting manifestations. The proband is a 17-year-old woman who presented with lower limb pain and proximal muscle weakness. Skeletal radiographs of the long bones revealed cortical, periosteal, and endosteal thickenings, predominantly affecting the diaphyses of the long bones. On detailed evaluation, there was a strong family history of bone disorder with similar symptoms of pain and radiological findings in several family members. Exon sequencing of the TGFβ1 gene was performed in available family members. Based on clinical and radiographic studies and its familial nature, a diagnosis of CED was made and confirmed by mutation analysis. A heterozygous G to A transition in exon 4 of the TGFβ1 gene (R218H) was detected in 5 out of 10 available family members, including 4 affecteds and 1 asymptomatic individual. Many of our affected individuals responded to glucocorticoids and cortical windowing. CED is a rare genetic disease with variable clinical manifestations and incomplete penetrance. CED needs to be considered in the differential diagnosis of nonspecific limb pain and waddling gait in all young individuals.
Literatur
1.
Zurück zum Zitat Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S et al (2006) Camurati–Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet 43:1–11PubMedCrossRef Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S et al (2006) Camurati–Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet 43:1–11PubMedCrossRef
2.
Zurück zum Zitat Vanhoenacker FM, Janssens K, Van Hul W, Gershoni-Baruch R, Brik R, De Schepper AM (2003) Camurati–Engelmann disease: review of radioclinical features. Acta Radiol 44:430–434PubMed Vanhoenacker FM, Janssens K, Van Hul W, Gershoni-Baruch R, Brik R, De Schepper AM (2003) Camurati–Engelmann disease: review of radioclinical features. Acta Radiol 44:430–434PubMed
3.
Zurück zum Zitat Janssens K, Gershoni-Baruch R, Van Hul E, Brik R, Guañabens N, Migone N et al (2000) Localisation of the gene causing diaphyseal dysplasia Camurati–Engelmann to chromosome 19q3. J Med Genet 37:245–249PubMedCrossRef Janssens K, Gershoni-Baruch R, Van Hul E, Brik R, Guañabens N, Migone N et al (2000) Localisation of the gene causing diaphyseal dysplasia Camurati–Engelmann to chromosome 19q3. J Med Genet 37:245–249PubMedCrossRef
4.
Zurück zum Zitat Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralston S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen L, Van Hul W (2000) Mutations in the gene encoding the latency-associated peptide of TGF-beta1 cause Camurati–Engelmann disease. Nat Genet 26:273–275PubMedCrossRef Janssens K, Gershoni-Baruch R, Guanabens N, Migone N, Ralston S, Bonduelle M, Lissens W, Van Maldergem L, Vanhoenacker F, Verbruggen L, Van Hul W (2000) Mutations in the gene encoding the latency-associated peptide of TGF-beta1 cause Camurati–Engelmann disease. Nat Genet 26:273–275PubMedCrossRef
5.
Zurück zum Zitat Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M et al (2000) Domain-specific mutations in TGFB1 result in Camurati–Engelmann disease. Nat Genet 26:19–20PubMedCrossRef Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M et al (2000) Domain-specific mutations in TGFB1 result in Camurati–Engelmann disease. Nat Genet 26:19–20PubMedCrossRef
6.
Zurück zum Zitat Bonewald LF, Dallas S (1994) Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55:350–357PubMedCrossRef Bonewald LF, Dallas S (1994) Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55:350–357PubMedCrossRef
7.
Zurück zum Zitat Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ (2000) A role for TGFβ1 in osteoclast differentiation and survival. J Cell Sci 113:2445–2453PubMed Fuller K, Lean JM, Bayley KE, Wani MR, Chambers TJ (2000) A role for TGFβ1 in osteoclast differentiation and survival. J Cell Sci 113:2445–2453PubMed
8.
Zurück zum Zitat Sparkers RS, Graham CB (1972) Camurati–Engelmann disease: genetics and clinical manifestations with review of literature. J Med Genet 9:73–85CrossRef Sparkers RS, Graham CB (1972) Camurati–Engelmann disease: genetics and clinical manifestations with review of literature. J Med Genet 9:73–85CrossRef
10.
Zurück zum Zitat Engelmann G (1929) Ein fall von ostheopathia hyperostotica (sclerotisans) multiplex infantilis. Forschritte auf dem Gebiete der Rontgenstrahlen und derNuklearmedizin 39:1101–1106 Engelmann G (1929) Ein fall von ostheopathia hyperostotica (sclerotisans) multiplex infantilis. Forschritte auf dem Gebiete der Rontgenstrahlen und derNuklearmedizin 39:1101–1106
11.
Zurück zum Zitat Crisp AJ, Brenton DP (1982) Engelmann’s disease of bone—a systemic disorder? Ann Rheum Dis 41:183–188PubMedCrossRef Crisp AJ, Brenton DP (1982) Engelmann’s disease of bone—a systemic disorder? Ann Rheum Dis 41:183–188PubMedCrossRef
12.
Zurück zum Zitat Inaoka T, Shuke N, Sato J et al (2001) Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati–Engelmann disease). Clin Nucl Med 26:680–682PubMedCrossRef Inaoka T, Shuke N, Sato J et al (2001) Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati–Engelmann disease). Clin Nucl Med 26:680–682PubMedCrossRef
13.
Zurück zum Zitat Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W (2003) Transforming growth factor-beta 1 mutations in Camurati–Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 278(9):7718–7724PubMedCrossRef Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W (2003) Transforming growth factor-beta 1 mutations in Camurati–Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem 278(9):7718–7724PubMedCrossRef
14.
Zurück zum Zitat Wallace SE, Lachman RS, Mekikian PB, Bui KK, Wilcox WR (2004) Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati–Engelmann disease): report of a four-generation pedigree, identification of a mutation in TGFβ1, and review. Am J Med Genet A 129A:235–247PubMedCrossRef Wallace SE, Lachman RS, Mekikian PB, Bui KK, Wilcox WR (2004) Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati–Engelmann disease): report of a four-generation pedigree, identification of a mutation in TGFβ1, and review. Am J Med Genet A 129A:235–247PubMedCrossRef
15.
Zurück zum Zitat Saraiva JM (1997) Progressive diaphyseal dysplasia: a three generation family with markedly variable expressivity. Am J Med Gen 71:348–352CrossRef Saraiva JM (1997) Progressive diaphyseal dysplasia: a three generation family with markedly variable expressivity. Am J Med Gen 71:348–352CrossRef
16.
Zurück zum Zitat Heymans O, Gebhart M, Alexiou J, Sokolow Y (1998) Camurati–Engelmann disease: effects of corticosteroids. Acta Clin Belg 53:189–192PubMed Heymans O, Gebhart M, Alexiou J, Sokolow Y (1998) Camurati–Engelmann disease: effects of corticosteroids. Acta Clin Belg 53:189–192PubMed
17.
Zurück zum Zitat Naveh Y, Alon U, Kaftori JK, Berant M (1985) Progressive diaphyseal dysplasia: evaluation of corticosteroid therapy. Pediatrics 75:321–323PubMed Naveh Y, Alon U, Kaftori JK, Berant M (1985) Progressive diaphyseal dysplasia: evaluation of corticosteroid therapy. Pediatrics 75:321–323PubMed
18.
Zurück zum Zitat Bas F, Darendeliler F, Petorak I et al (1999) Deflazacort treatment in progressive diaphyseal dysplasia (Camurati–Engelmann disease). J Paediatr Child Health 35:401–405PubMedCrossRef Bas F, Darendeliler F, Petorak I et al (1999) Deflazacort treatment in progressive diaphyseal dysplasia (Camurati–Engelmann disease). J Paediatr Child Health 35:401–405PubMedCrossRef
19.
Zurück zum Zitat Verbruggen LA, Bossuyt A, Schreuer R, Somers G (1985) Clinical and scintigraphic evaluation of corticosteroid treatment in a case of progressive diaphyseal dysplasia. J Rheumatol 12:809–813PubMed Verbruggen LA, Bossuyt A, Schreuer R, Somers G (1985) Clinical and scintigraphic evaluation of corticosteroid treatment in a case of progressive diaphyseal dysplasia. J Rheumatol 12:809–813PubMed
20.
Zurück zum Zitat Van Staa TP, Leufkens HG, Abenhaim L et al (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383–1389CrossRef Van Staa TP, Leufkens HG, Abenhaim L et al (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383–1389CrossRef
21.
Zurück zum Zitat Raffaelli P, Ronzini MF (1988) Camurati–Engelmann’s disease: a case report. Ital J Orthop Traumatol 14:267–271PubMed Raffaelli P, Ronzini MF (1988) Camurati–Engelmann’s disease: a case report. Ital J Orthop Traumatol 14:267–271PubMed
22.
Zurück zum Zitat Lazzarone C, Cartesegna M, Crova M, Calorio D (1983) Progressive diaphyseal dysplasia: Camurati–Engelmann’s disease. Ital J Orthop Traumatol 9:109–114PubMed Lazzarone C, Cartesegna M, Crova M, Calorio D (1983) Progressive diaphyseal dysplasia: Camurati–Engelmann’s disease. Ital J Orthop Traumatol 9:109–114PubMed
Metadaten
Titel
Camurati–Engelmann Disease (Progressive Diaphyseal Dysplasia): Reports of an Indian Kindred
verfasst von
Sanjay Kumar Bhadada
Subbiah Sridhar
Ellen Steenackers
Vandana Dhiman
Geert Mortier
Anil Bhansali
Wim Van Hul
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 2/2014
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-013-9804-9

Weitere Artikel der Ausgabe 2/2014

Calcified Tissue International 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.